Showing results (421-430 of 3,072) with videos related to

Sort By:
Pageof 308
Chemotherapy|December 21, 2004
Phase I trial using weekly administration of gemcitabine and docetaxel in patients with advanced pancreatic carcinomaF Meyer, A Lueck, A Hribaschek, et al.
Chemotherapy|July 30, 2004
Pharmacodynamics and bactericidal activity of gatifloxacin in experimental pneumonia caused by penicillin-resistant Streptococcus pneumoniaeKatsunori Yanagihara, Yuichi Fukuda, Yoshitsugu Miyazaki, et al.
Chemotherapy|July 24, 2004
A new perspective on cardiotoxicity of 5-fluorouracil. A novel research tool 'cardiac ultrasonic integrated backscatter analysis' indicates transient, subclinical myocardial dysfunction due to high-dose leucovorin and infusional 5-fluorouracil regimenSabri Barutca, Ceyhun Ceyhan, Nezih Meydan, et al.
Chemotherapy|July 12, 2005
European status of resistance in nosocomial infectionsHerman Goossens
Chemotherapy|June 30, 2005
Influence of the cyto-protective agent amifostine on the pharmacokinetics of low-dose PaclitaxelOscar Juan, Amparo Rocher, Agustín Sánchez, et al.
Chemotherapy|June 28, 2005
In vitro activity of telithromycin against respiratory tract pathogens in comparison with other antimicrobial agentsThomas K W Ling, Ching Ching Lee
Chemotherapy|January 1, 1992
Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosaH J Leying, K H Büscher, W Cullmann, et al.
Chemotherapy|September 29, 2004
Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infectionsP Nenoff, U-F Haustein, N Hittel
Chemotherapy|November 6, 2004
Uniform potent activity of the antiproliferative metal chelate trans-bis(resorcylaldoximato)copper(II) against a large panel of human tumor cell lines in vitroHannu Elo
Chemotherapy|January 1, 1992
The threat of resistance to the new oral cephalosporinsW Cullmann
Pageof 308